Patients
Biosimilars & patient access independent of geographies or s...
Rebecca Guntern, Sandoz' CCO, discusses the ‘golden decade’ for generics and biosimilars as so many blockbuster drugs come off patent.
Patients
Towards a healthier world: Momentum in UK health system tran...
In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Lee-Ann Farrell, Head of National Programmes at Johnson & Johnson.
Digital
Trustworthy and novel AI in clinical trial planning, with Kr...
Norstella's Kris Kaneta discusses why patient-level data is pharma's most important asset, as well as expanding the efficacy of AI for clinical trials
Patients
The cardio-renal-metabolic space and obesity as a chronic di...
The podcast welcomes Dr Ramy Younes, corporate VP, global head of clinical development, cardiorenalmetabolism, at Boehringer Ingelheim.
R&D
On the power of T-cells, with Cedrik Britten
Dr Cedrik Britten, chief medical officer at Immatics, discusses novel PRAME-directed T-cell immunotherapies.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
